Vote Scores

Home / Companies / Compass Therapeutics, Inc. / 13 Jun 2024

Meeting · year to 30 June 202445 filers reporting

Compass Therapeutics, Inc.: meeting of 13 Jun 2024

Votes reported on Form N-PX, item by item

45 Form N-PX filers reported votes at the Compass Therapeutics, Inc. meeting of 13 Jun 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 79.9% of reported votes for; 20 filers withheld from or voted against at least one nominee.

164 vote records from 45 filers. 1 of the 45 filers that marked the item either way voted against management.

57.8% for0.0% against42.2% other2.2% against management45 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

82 vote records from 45 filers. 0 of the 45 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management45 filers100.0% for0.0% against0.0% against management9,658,493 reported shares

How the largest families voted

Family1. Directors2. Auditor
VanguardForFor
BlackRock and iSharesForFor
FidelityForFor
State Street and SPDRForFor
EquitableForFor
Charles SchwabForFor
Nuveen and TIAAForFor
ProShares and ProFundsSplit or no voteFor
John Hancock and ManulifeSplit or no voteFor
Morgan Stanley, Eaton Vance and CalvertForFor
Jackson National fundsAbstain or withhold *For
T. Rowe PriceForFor
Lincoln FinancialForFor
VoyaSplit or no voteFor
NationwideSplit or no voteFor
Victory CapitalSplit or no voteFor
Brighthouse FundsSplit or no voteFor
Guggenheim and RydexSplit or no voteFor
PrincipalSplit or no voteFor
Pacific Life fundsForFor
Global XForFor
DWSSplit or no voteFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Compass Therapeutics, Inc. meeting?

45 Form N-PX filers reported votes at the meeting of 13 Jun 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Compass Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Compass Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Compass Therapeutics, Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.